Allarity Therapeutics, Inc. filed an 8-K report on September 22, 2025, announcing a private equity placement to sell 1,562,500 shares of common stock at $1.60 each, generating approximately $2.5 million before fees. This agreement includes an option for the investor to purchase additional shares worth up to $7.5 million within 90 days.